These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 5047166)

  • 1. Paracingulate Sulcus Morphology and Hallucinations in Clinical and Nonclinical Groups.
    Garrison JR; Fernyhough C; McCarthy-Jones S; Simons JS; Sommer IEC
    Schizophr Bull; 2019 Jun; 45(4):733-741. PubMed ID: 30380115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuated Post-Movement Beta Rebound Associated With Schizotypal Features in Healthy People.
    Hunt BAE; Liddle EB; Gascoyne LE; Magazzini L; Routley BC; Singh KD; Morris PG; Brookes MJ; Liddle PF
    Schizophr Bull; 2019 Jun; 45(4):883-891. PubMed ID: 30239878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing continuum models of psychosis: No reduction in source monitoring ability in healthy individuals prone to auditory hallucinations.
    Garrison JR; Moseley P; Alderson-Day B; Smailes D; Fernyhough C; Simons JS
    Cortex; 2017 Jun; 91():197-207. PubMed ID: 27964941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining the Psychosis Continuum.
    DeRosse P; Karlsgodt KH
    Curr Behav Neurosci Rep; 2015 May; 2(2):80-89. PubMed ID: 26052479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Overview of the Association between Schizotypy and Dopamine.
    Mohr C; Ettinger U
    Front Psychiatry; 2014; 5():184. PubMed ID: 25566103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Duality of Schizotypy: Is it Both Dimensional and Categorical?
    Mason OJ
    Front Psychiatry; 2014; 5():134. PubMed ID: 25309463
    [No Abstract]   [Full Text] [Related]  

  • 7. Is disorganization a feature of schizophrenia or a modifying influence: evidence of covariation of perceptual and cognitive organization in a non-patient sample.
    Feigenson KA; Gara MA; Roché MW; Silverstein SM
    Psychiatry Res; 2014 Jun; 217(1-2):1-8. PubMed ID: 24656898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics, cognition, and neurobiology of schizotypal personality: a review of the overlap with schizophrenia.
    Ettinger U; Meyhöfer I; Steffens M; Wagner M; Koutsouleris N
    Front Psychiatry; 2014; 5():18. PubMed ID: 24600411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whither the psychosis-neurosis borderline.
    Kelleher I; Cannon M
    Schizophr Bull; 2014 Mar; 40(2):266-8. PubMed ID: 24436054
    [No Abstract]   [Full Text] [Related]  

  • 10. Erotomania revisited: thirty-four years later.
    Jordan HW; Lockert EW; Johnson-Warren M; Cabell C; Cooke T; Greer W; Howe G
    J Natl Med Assoc; 2006 May; 98(5):787-93. PubMed ID: 16749657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High dose diazepam in schizophrenia.
    Beckmann H; Haas S
    Psychopharmacology (Berl); 1980; 71(1):79-82. PubMed ID: 6779328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysergic acid diethylamide (LSD-25) and schizophrenic reactions. A comparative study.
    Langs RJ; Barr HL
    J Nerv Ment Dis; 1968 Aug; 147(2):163-72. PubMed ID: 5677324
    [No Abstract]   [Full Text] [Related]  

  • 13. Psychopathology and psychophysiology of minimal LSD-25 dosage; a preliminary dosage-response spectrum.
    GREINER T; BURCH NR; EDELBERG R
    AMA Arch Neurol Psychiatry; 1958 Feb; 79(2):208-10. PubMed ID: 13497365
    [No Abstract]   [Full Text] [Related]  

  • 14. Electrophysiological studies of psychiatric problems.
    Shagass C
    Rev Can Biol; 1972; 31():Suppl:77-95. PubMed ID: 4262227
    [No Abstract]   [Full Text] [Related]  

  • 15. Personality.
    Helson R; Mitchell V
    Annu Rev Psychol; 1978; 29():555-85. PubMed ID: 341790
    [No Abstract]   [Full Text] [Related]  

  • 16. The schizophrenias as nervous types.
    Claridge G
    Br J Psychiatry; 1972 Jul; 121(560):1-17. PubMed ID: 5047166
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of LSD-25 on creativity and tolerance to regression.
    Zegans LS; Pollard JC; Brown D
    Arch Gen Psychiatry; 1967 Jun; 16(6):740-9. PubMed ID: 5338679
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.